These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9700981)

  • 1. Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis.
    Szilvássy Z; Ferdinandy P; Cluff CW; Elliott GT
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):206-12. PubMed ID: 9700981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning.
    Szilvassy Z; Ferdinandy P; Bor P; Jakab I; Lonovics J; Koltai M
    Am J Physiol; 1994 May; 266(5 Pt 2):H2033-41. PubMed ID: 8203601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits: possible role of cardiac cyclic nucleotides.
    Szilvassy Z; Jakab I; Bor P; Koltai M; Tarrade T; Esanu A; Braquet PG; Lonovics J
    Coron Artery Dis; 1993 May; 4(5):443-52. PubMed ID: 8261221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
    Zhao L; Kirsch CC; Hagen SR; Elliott GT
    J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cromakalim and cicletanine against pacing-induced myocardial ischemia in conscious rabbits.
    Szilvassy Z; Koltai M; Ferdinandy P; Jakab I; Lonovics J; Tarrade T; Allard M; Braquet PG
    Life Sci; 1994; 54(9):PL125-30. PubMed ID: 8114606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits.
    Szilvassy Z; Jakab I; Ferdinandy P; Koltai M; Lonovics J; Tarrade T; Braquet PG
    Life Sci; 1993; 53(1):PL13-8. PubMed ID: 8390593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia.
    Szilvassy Z; Ferdinandy P; Szilvassy J; Nagy I; Karcsu S; Lonovics J; Dux L; Koltai M
    J Mol Cell Cardiol; 1995 Dec; 27(12):2559-69. PubMed ID: 8825877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein.
    Yoshida K; Maaieh MM; Shipley JB; Doloresco M; Bernardo NL; Qian YZ; Elliott GT; Kukreja RC
    Mol Cell Biochem; 1996 Jun; 159(1):73-80. PubMed ID: 8813712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart.
    Baxter GF; Goodwin RW; Wright MJ; Kerac M; Heads RJ; Yellon DM
    Br J Pharmacol; 1996 Apr; 117(8):1685-92. PubMed ID: 8732277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
    Yao Z; Rasmussen JL; Hirt JL; Mei DA; Pieper GM; Gross GJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):653-63. PubMed ID: 7505370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cardiac workload by adrenoceptor agonists for the estimation of potential antiischemic activity in a conscious rabbit model.
    Kovanecz I; Papp JG; Szekeres L
    J Pharmacol Toxicol Methods; 1997 Apr; 37(3):149-59. PubMed ID: 9253751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
    Végh A; György K; Rastegar MA; Papp JG; Parratt JR
    Eur J Pharmacol; 1999 Oct; 382(2):81-90. PubMed ID: 10528142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
    Elliott GT; Comerford ML; Smith JR; Zhao L
    Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
    Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog.
    Yao Z; Auchampach JA; Pieper GM; Gross GJ
    Cardiovasc Res; 1993 May; 27(5):832-8. PubMed ID: 8394211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic myocardial preconditioning with monophosphoryl lipid A (MLA) reduces infarct size and stunning in dogs and rabbits.
    Elliott GT
    Ann N Y Acad Sci; 1996 Sep; 793():386-99. PubMed ID: 8906181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic preconditioning with monophosphoryl lipid A is abolished by 5-hydroxydecanoate, a specific inhibitor of the K(ATP) channel.
    Janin Y; Qian YZ; Hoag JB; Elliott GT; Kukreja RC
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):337-42. PubMed ID: 9733344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.